Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Return on Equity [ROE] (2009 - 2026)

Updated

Bristol Myers Squibb's Return on Equity [ROE] was 40.42% in Q3 2026, up 6.92 percentage points from 33.51% a year earlier but down 3.30 percentage points from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Bristol Myers Squibb came in at 40.44%, up 79.38 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of +60.52 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -38.95% in FY2024 (-65.48 pp), 26.53% in FY2023 (+7.63 pp), 18.91% in FY2022 (-0.08 pp) and 18.99% in FY2021 (+39.07 pp).
  • Quarterly Return on Equity [ROE] has moved between -53.19% (Q4 2024) and 43.72% (Q2 2026) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has increased for seven straight quarters, with an average year-over-year change of +30.02 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2025 (a gain of 91.22 percentage points); the worst was Q4 2024 (a drop of 80.66 percentage points).
  • Per Business Quant data, BMY's Return on Equity [ROE] in the three quarters before Q3 2026 was 43.72% (Q2 2026), 37.67% (Q1 2026) and 38.03% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 19.33%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.63%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 21.60%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 72.13%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -31.17%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 4.66%
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 40.42%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 40.42%
Jun 30, 2026 43.72%
Mar 31, 2026 37.67%
Dec 31, 2025 38.03%
Sep 30, 2025 33.51%
Jun 30, 2025 29.00%
Mar 31, 2025 32.14%
Dec 31, 2024 -53.19%
Sep 30, 2024 -42.29%
Jun 30, 2024 -38.84%
Mar 31, 2024 -26.65%
Dec 31, 2023 27.47%
Sep 30, 2023 27.18%
Jun 30, 2023 24.96%
Mar 31, 2023 23.27%
Dec 31, 2022 19.87%
Sep 30, 2022 20.47%
Jun 30, 2022 20.64%
Mar 31, 2022 18.53%
Dec 31, 2021 19.14%
API Access

Bristol Myers Squibb Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BMY&period=max&api_key=YOUR_API_KEY